Published • loading... • Updated
Anvisa Defines Ozempic's Brazilian Rival Price
Summary by A TARDE
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The first semiglutide developed by a Brazilian pharmacist, Ozivy, manufactured by EMS, surpassed the last regulatory step necessary to debut in the country's pharmaceutical networks.The National Agency for Health Surveillance (Anvisa), through the Chamber of Regulation of the Market for Medicines (CMED), officialized the Maximum Consumer Price (MPC) of the product.The regulator established the financial ceiling of the national drug on the same l…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
